Search

everythinglearnresearchcommunity

for

Search:↓

Epithelial stem cells are crucial for tissue renewal and repair, and understanding them could improve treatments for damage and cancer.

VDR regulation varies by tissue and is crucial for its biological functions.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Genomic approach finds new possible treatments for hair loss.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Patched1 helps prevent tumors by controlling cell growth.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

The enzymes Tet2 and Tet3 are important for skin cell development and hair growth.

Four-amino acid part makes enzyme sensitive to finasteride.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Platelet-rich plasma may help hair follicle cells grow by affecting certain genes and pathways.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

Rat dermal papilla cells have unique genes crucial for hair growth.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.